Detail
LncRNA Name | GUARDIN |
Synonyms | NA |
Region | NA Sequence |
Ensembl | NA |
RefSeq | NA |
Circulating | ✘ |
Drug-resisitant | ✘ |
Prognostic | ✔ |
MiRNA | ✔ |
Variant | ✘ |
TF | ✘ |
Methylation | ✘ |
Cancer Name | colon cancer |
ICD-0-3 | C18 |
Methods | Microarray, Luciferase reporter assay, in vitro knockdown, RNAi etc. |
Sample | cell line (HCT116, U2OS, A549, H1299, 293T and HAFF), colon cancer tissues |
Expression Pattern | up-regulated |
Function Description | GUARDIN is necessary for preventing chromosome end-to-end fusion through maintaining the expression of telomeric repeat-binding factor 2 (TRF2) by sequestering microRNA-23a.Moreover, GUARDIN also sustains breast cancer 1 (BRCA1) stability by acting as an RNA scaffold to facilitate the heterodimerization of BRCA1 and BRCA1-associated RING domain protein 1 (BARD1).As such, GUARDIN silencing triggered apoptosis and senescence,enhanced cytotoxicity of additional genotoxic stress and inhibited cancer xenograft growth. Thus, GUARDIN may constitute a target for cancer treatment. GUARDIN functions to regulate TRF2 and IRF1 through sequestering miR-23a. |
Pubmed ID | 29593331 |
Year | 2018 |
Title | GUARDIN is a p53-responsive long non-coding RNA that is essential for genomic stability. |
External Links |
Links for GUARDIN | GenBank HGNC lncrnadb Noncode |
Links for colon cancer | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.